Topic 9: Management's Discussion and Analysis of Financial Position and Results of Operations (MD&A)
9100 MD&A Objectives
|
Section
|
Description
|
Last updated
|
|---|---|---|
|
9110
|
Overall Objectives [S-K 303(a)]
|
8/22/2025
|
9110 Overall Objectives [S-K 303(a)]
9110.1 MD&A is a narrative explanation of the
financial statements and other statistical data that the registrant believes
will enhance a readers’ understanding of its financial condition, cash flows
and other changes in financial condition and results of operation.
Registrants should discuss and analyze, from management’s perspective:
-
Material information relevant to an assessment of the financial condition and results of operations of the registrant, including an evaluation of the amounts and certainty of cash flows from operations and from outside sources;
-
Material events and uncertainties known to management that are reasonably likely to cause reported financial information not to be indicative of future operating results or of future financial condition; and
-
Matters that have had a material impact on reported operations, as well as matters that are reasonably likely based on management’s assessment to have a material impact on future operations.
9110.2 MD&A should not consist of generic or boilerplate disclosure. Rather, it should reflect the facts and circumstances specific to each individual registrant. S-K 303 is a "principles-based" disclosure requirement. It is intended to provide management with flexibility to describe the financial matters impacting the registrant.
9200 General Requirements
|
Section
|
Description
|
Last updated
|
|---|---|---|
|
9200
|
General Requirements
|
8/22/2025
|
|
9210
|
Liquidity and Capital Resources [S-K 303(b)(1)]
|
8/22/2025
|
|
9220
|
Results of Operations [S-K 303(b)(2)]
|
8/22/2025
|
|
9230
|
Key Performance Indicators and Metrics [Release No.
33-10751 (January 30, 2020)]
|
8/22/2025
|
|
9240
|
Disclosure of Known Trends and Uncertainties
|
8/22/2025
|
|
9250
|
Interim Period Requirements [S-K
303(c)]
|
8/22/2025
|
|
9260
|
Safe Harbor Provisions [Instruction 6 to S-K 303(b)]
|
8/22/2025
|
|
9270
|
SAB Topic 11M (SAB 74)
|
6/30/2013
|
The MD&A requirements with respect to the full fiscal years
presented in the financial statements are set forth in S-K 303(b). S-K 303(c)
sets forth the requirements for MD&A related to interim periods. See Section
10220.4 for MD&A requirements for EGCs.
|
Note: Release No. 33-8350 provided some suggested
ways to improve MD&A. These suggestions included
adding an overview section to MD&A, presenting the
most material information early in the discussion, using
headers, bullets or tabular presentations to improve the
overall readability and omitting information that is no
longer material or helpful. It should be noted these
suggestions are not part of the requirements set forth
in S-K 303.
|
9210 Liquidity and Capital Resources [S-K 303(b)(1)]
9210.1 A key objective of this discussion is to
provide an analysis of the registrant's ability to generate and obtain
adequate amounts of cash to meet its requirements and its plans for cash in
the short-term (i.e., the next 12 months from the most recent fiscal period
end required to be presented) and separately in the long-term (i.e., beyond
the next 12 months).
9210.2 Any known trends, or any known demands,
commitments, events or uncertainties that will result in, or are reasonably
likely to result in, the registrant’s liquidity increasing or decreasing in
a material way should be discussed. To the extent a material deficiency is
identified, the registrant should disclose the course of action that it has
taken or proposes to take to remedy the deficiency. The discussion should
also identify and separately describe internal and external sources of
liquidity, as well as briefly discuss any material unused sources of liquid
assets. [S-K 303(b)(1)(i)]
9210.3 The requirements of the disclosures related
to capital resources include a discussion of the registrant’s material cash
requirements, including material commitments for capital expenditures, as of
the end of the latest fiscal period; the anticipated source of funds needed
to satisfy such cash requirements; and the general purpose of such
requirements. The registrant should also describe any known material trends,
favorable or unfavorable, in the registrant's capital resources and indicate
any reasonably likely material changes in the mix and relative cost of such
resources. The discussion must consider changes among equity, debt, and any
off-balance sheet financing arrangements. [S-K 303(b)(1)(ii)]
9210.4 The liquidity and capital resources discussion should address:
- Material cash requirements from known contractual obligations, which may include lease obligations, purchase obligations, or other liabilities reflected on the registrant's balance sheet; [Instruction 4 to S-K 303(b)]
- Commitments or obligations, including contingent obligations, arising from arrangements with unconsolidated entities or persons that have or are reasonably likely to have a material current or future effect on a registrant's financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, cash requirements or capital resources. Commitments or obligations must be provided even when the arrangement(s) results in no obligations being reported in the registrant's consolidated balance sheets. Such off-balance sheet arrangements may include: Guarantees; retained or contingent interests in assets transferred; contractual arrangements that support the credit, liquidity or market risk for transferred assets; obligations that arise or could arise from variable interests held in an unconsolidated entity; or obligations related to derivative instruments that are both indexed to and classified in a registrant's own equity under U.S. GAAP. [Instruction 8 to S-K 303(b)]
9210.5 It may be necessary for the liquidity and capital resources discussion to address debt instruments, guarantees and related covenants. Disclosure is likely to be necessary if:
- The registrant is, or is reasonably likely to be, in breach of debt covenants or
- Debt covenants impact the registrant's ability to obtain additional debt or equity financing.
9210.6 Improving Liquidity and Capital Resources
-
Registrants should not simply repeat items reported in the statement of cash flows. Registrants should focus on the primary drivers of and other material factors necessary to an understanding of the registrant's cash flows and the indicative value of historical cash flows.
-
Registrants should describe cash flows from operating, investing and financing activities associated with discontinued operations separately from continuing operations if that information is not apparent from the cash flow statement. Additionally, registrants should describe how the company's liquidity is reasonably likely to be affected by the absence of cash flows (or negative cash flows) associated with discontinued operations. Refer to Section 9830.1.
9220 Results of Operations [S-K 303(b)(2)]
9220.1 The discussion that is provided with respect
to the results of operations should not consist merely of numeric dollar and
percentage changes measured from period to period of various line items on
the statement of comprehensive income. The focus should be on an analysis of
the factors that caused these changes and any material offsetting changes
that occurred. The analysis must describe the underlying reasons for these
material changes in quantitative and qualitative terms. In providing this
analysis, registrants may find it helpful to include a discussion of key
variables and financial measures management utilizes in managing the
business. These variables may be non-financial in nature or may represent
industry specific metrics.
9220.2 The following disclosures are required by S-K
303(b)(2):
-
Any unusual or infrequent events or transactions or any significant economic changes that materially affected the amount of reported income from continuing operations and in each case, indicate the extent to which income was so affected;
-
Significant components of revenues and expenses that, in the registrant’s judgment, would be material to an understanding of the registrant’s results of operations (e.g., segmental information);
-
Any known trends or uncertainties that have had or that are reasonably likely to have a material favorable or unfavorable impact on net sales or revenues or income from continuing operations;
-
If events that are reasonably likely to cause a material change in the relationship between costs and revenues (such as known or reasonably likely future increases in cost of labor or materials or price increases or inventory adjustments), the change in the relationship must be disclosed; and
-
To the extent there are material changes from period to period in net sales or revenue, describe the extent to which such changes are attributable to changes in prices or to changes in the volume or amount of goods or services being sold or to the introduction of new products or services.
9220.3 Where in the registrant's judgment a
discussion of segment information and/or of other subdivisions (e.g.,
geographic areas, product lines) of the registrant's business would be
necessary to an understanding of such business, the discussion must focus on
each relevant reportable segment and/or other subdivision of the business
and on the registrant as a whole. For many registrants, segment analysis is
necessary to enable a reader to understand the consolidated amounts, but it
should not result in repetitive disclosure that lengthens MD&A
unnecessarily, or obscures salient information. The discussion and analysis
of segments may be integrated with the discussion of the consolidated
amounts to avoid unnecessary duplication. All material components of the
registrant’s results of operations, including those that may not be
allocated to the segments in determining the segment profit or loss (such as
certain corporate overhead items or income taxes for example) should be
discussed.
9220.4 Registrants should consider discussing and
analyzing the tax implications related to material transactions, trends and
other important items impacting their business as disclosed elsewhere in
MD&A.
A discussion of the nature and impact of significant tax rate reconciling
items should also be considered. For example, discuss the tax rate
reconciling item resulting from a change in assumptions related to an
unrecognized tax benefit or a different final resolution related to the
unrecognized benefit. Similarly, when uncertain tax positions are a critical
accounting estimate,, MD&A should address why the assumptions were
changed or why the actual resolution differed from management’s assumption.
(Last updated: 9/30/2010)
9220.5 Registrants should address the underlying reasons for changes in the price versus volume mix. For example, if sales declined because the volume of goods sold decreased by 20%, but this was offset by a 10% increase in price, the discussion in MD&A should not stop once it identifies the price and volume components. In this example, the underlying factors that contributed to the decline in volume as well as the increase in selling prices should also be discussed. In addition, discussions about changes in the price vs. volume mix should consider changes in foreign currency fluctuations.
9220.6 The results of operations may not always be prepared on a consistent basis. This will occur, for example, when there has been a change in basis in the underlying financial statements. This might occur in the following situations:
- When there has been a material acquisition (either the acquisition of a business that is significant to the registrant or predecessor/successor step-up in basis) during the period;
- When pushdown accounting has been applied; or
- When the registrant has adopted fresh-start accounting upon its emergence from bankruptcy.
9220.7 When events such as those described in 9220.6
occur, registrants should consider whether the discussion of the results of
operations and financial condition set forth in the audited financial
statements included in the filing should be supplemented by a discussion
based upon pro forma information. This supplemental discussion may be
meaningful in the case of a material acquisition, but generally would not be
appropriate in the case of fresh-start accounting. A determination as to
whether a discussion of the audited financial statements should be
supplemented by a discussion based on pro forma information should take into
consideration all of the facts and circumstances surrounding the
transaction, the nature of the pro forma adjustments made, and the overall
meaningfulness of any such supplemental pro forma discussion.
9220.8 If it is determined that a supplemental discussion
in MD&A based on pro forma information is appropriate, then the pro
forma information may be presented in a format consistent with S-X Article
11. Other formats, such as the footnote pro forma information specified by
ASC 805, may also be appropriate depending on the particular facts and
circumstances. It would be inappropriate to merely combine information for
the pre-and post-transaction periods without reflecting all relevant pro
forma adjustments required by S-X Article 11. Pro forma financial
information should only be prepared for the most recent fiscal year and
interim period prior to the transaction occurring. However, the staff will
not object to the registrant providing (i) a pro forma statement of
comprehensive income for the corresponding prior interim period or (ii) pro
forma revenue and cost of revenue information for the prior fiscal year if
meaningful for the discussion of trends in MD&A, as further discussed in
the note below.
If pro forma results are discussed in MD&A, they should not be discussed
in isolation. Supplemental discussions based on S-X Article 11 pro forma
financial information should not be presented with greater prominence than
the discussion of the historical financial statements required by S-K
303.
For example, assume a material acquisition occurs on August 31, 20X7, and the
registrant is a calendar year-end company. In accordance with the Form 8-K
requirements, pro forma financial information prepared in accordance with
S-X Article 11 is prepared for the year ended December 31, 20X6 and the
interim period ended June 30, 20X7 and filed on the Form 8-K. When preparing
its MD&A for the Form 10-K for the year ended December 31, 20X7, the
registrant could elect to supplement the discussion of its historical
results with a discussion based on S-X Article 11 pro forma financial
information for the year ended December 31, 20X7 that gives effect to the
August 31, 20X7 acquisition. The pro forma financial information for the
year ended December 31, 20X7 information would then be compared to the pro
forma financial information for the year ended December 31, 20X6 previously
filed via a Form 8-K. This discussion would be in addition to a comparison
of the audited financial statements, which would reflect the acquisition
occurring in mid-20X7. A supplemental discussion based on pro forma
financial information for the year ended December 31, 20X5, if deemed
relevant, should be limited to revenues and costs of revenues. The
comparison of results of operations and financial condition for the year
ended December 31, 20X5 to December 31, 20X6 would be on an as reported (and
audited) basis and would not reflect any impact of the acquisition. In its
Form 10-K for the year ended December 31, 20X8, the registrant may carry
forward the discussion of the pro forma results for the year ended December
31, 20X6 and 20X7 as a supplement to the discussion of the audited financial
statements. No adjustments would be appropriate or necessary to the year
ended December 31, 20X8 as the acquisition would be reflected in the audited
financial statements for the entire year.
|
NOTE: S-X 11-02(c)(2)(i) ordinarily prohibits the
disclosure of pro forma information for annual
periods prior to the most recent fiscal year
preceding the August 20X7 acquisition (i.e., fiscal
year 20X5 and prior years are prohibited). This
prohibition differs from the above example, in which
the company is simply including previously filed pro
forma information for the purpose of providing a
supplemental comparison of pro forma results in the
20X7 Form 10-K. The staff would not object to the
presentation in the above example even if the pro
forma information had not been previously filed
(e.g., in an IPO situation, where the company did
not have an obligation to file pro forma information
related to the August 20X7 acquisition; the staff
would look to what the company’s pro forma
disclosure obligation would have been, had it filed
a registration statement at that time). In the above example, because the business combination occurred in August 20X7,
pro forma information for 20X5 (the annual period
prior to the most recent fiscal year), is not
permitted. Companies may provide pro forma
information related to 20X5 in MD&A when
meaningful for the discussion of trends, provided
that such information is not in more detail than
revenues and cost of revenues. More comprehensive
presentations (through operating income, for
example) can be misleading because they cannot
meaningfully or accurately depict what operating
results would have been had the transaction occurred
at the earlier date. If a company believes that in
its unique situation the presentation in a greater
level of detail is necessary to understand the
implications of the transaction, the company is
encouraged to discuss the issue with the staff prior
to filing. |
9220.9 Disclosure should be provided to explain how
the pro forma presentation was derived, why management believes the
presentation to be useful, and any potential risks associated with using
such a presentation (the potential that such results might not necessarily
be indicative of future results for example, depending on how the
information has been prepared, and the period that it covers). Typically,
the presentation of complete pro forma financial information (reflecting the
adjustments) in MD&A will be necessary in order to facilitate an
understanding of the basis of the information being discussed. (In the
circumstances described in the example in Section 9220.8, this presentation would
include both 20X6 and 20X7.) However, there may be situations where the pro
forma adjustments are limited in number and easily understood so that
narrative disclosure of the adjustments alone will be sufficient.
9220.10 MD&A should fully explain the results
of operations. For example, MD&A should not merely state that the
increase in revenues and costs of revenues is due to a significant
acquisition. Rather, the contribution of the recent acquisition to total
revenues should be quantified to the extent possible, and any increase or
decrease in the underlying revenues of the pre-existing business should then
be addressed.
9220.11 [Reserved]
9230 Key Performance Indicators and Metrics [Release No. 33-10751 (January 30, 2020)]
9230.1 As discussed in Section 9110.1, management’s
discussion and analysis must be of the financial statements and other
statistical data that the registrant believes will enhance a reader's
understanding of the registrant's financial condition, cash flows and other
changes in financial condition and results of operations. Other statistical
data may include key performance indicators and metrics (“metrics”). When
metrics are disclosed, they should generally be accompanied by disclosure of:
-
a clear definition of the metric and how it is calculated;
-
a statement indicating the reasons why the metric provides useful information to investors; and
-
a statement indicating how management uses the metric in managing or monitoring the performance of the business.
Consideration should also be given to whether there are estimates or
assumptions underlying the metric (or its calculation) that should be
disclosed in order for the metric to not be materially misleading.
9230.2 If a company changes the method by which it
calculates or presents the metric from one period to another or otherwise,
the company should consider the need to disclose, to the extent material:
-
the differences in the way the metric is calculated or presented compared to prior periods,
-
the reasons for such changes,
-
the effects of any such change on the amounts or other information being disclosed and on amounts or other information previously reported, and
-
such other differences in methodology and results that wouldreasonably be expected to be relevant to an understanding of thecompany’s performance or prospects.
Depending on the significance of the change(s) in methodology and results,
the company should consider whether it is necessary to recast prior metrics
to conform to the current presentation and place the current disclosure in
an appropriate context.
9240 Disclosure of Known Trends and Uncertainties
9240.1 There are two assessments that management
must make where a trend, demand, commitment, event or uncertainty is known:
-
Is the known trend, demand, commitment event or uncertainty likely to come to fruition? If management determines that it is not reasonably likely to occur, no disclosure is required.
-
If management cannot make that determination, it must evaluate objectively the consequences of the known trend, demand, commitment, event or uncertainty, on the assumption that it will come to fruition. Disclosure is then required unless management determines that a material effect on the registrant’s financial condition or results of operations is not reasonably likely to occur. [Release No. 33-6835]
If a known trend, demand, commitment, event or uncertainty would reasonably be
likely to have a material effect on the registrant’s future results or
financial condition, disclosure is required. Known trends, demands,
commitments, events, or uncertainties that are not remote or where
management cannot make an assessment as to the likelihood that they will
come to fruition, and that would be reasonably likely to have a material
effect on the registrant’s future results or financial condition, were they
to come to fruition, should be disclosed if a reasonable investor would
consider omission of the information as significantly altering the mix of
information made available in the registrant’s disclosures. [Release No.
33-10890]
|
Note: “Reasonably likely” is a lower threshold
than “more likely than not” but a higher threshold
than “remote”. The concept of “reasonably likely” is
used in the context of disclosure for MD&A
purposes and is not intended to mirror the tests in
ASC 450 established to determine when accrual is
necessary, or when disclosure in the footnotes to
the financial statements is required.23
|
9240.2 [Reserved]
9240.3 [Reserved]
9240.4 [Reserved]
9240.5 [Reserved]
9240.6 [Reserved]
9240.7 [Reserved]
9240.8 [Reserved]
9250 Interim Period Requirements [S-K 303(c)]
9250.1 If interim period financial statements are
included or are required to be included by S-X Article 3, a management's
discussion and analysis of the financial condition and results of operations
must be provided to enable the reader to assess material changes in
financial condition and results of operations between the periods.
9250.2 Management’s discussion and analysis for
interim periods must include a discussion of material changes in:
-
financial condition from the end of the preceding fiscal year to the date of the most recent interim balance sheet provided. If the interim financial statements include an interim balance sheet as of the corresponding interim date of the preceding fiscal year, any material changes in financial condition from that date to the date of the most recent interim balance sheet must also be discussed. Such discussions may be combined.
-
results of operations with respect to the most recent fiscal year-to-date period for which a statement of comprehensive income is provided and the corresponding year-to-date period of the preceding fiscal year.
-
results of operations with respect to either the most recently completed quarter’s results of operations to either the corresponding quarter of the preceding fiscal year or the immediately preceding sequential quarter. If the latter quarter is discussed, then a registrant must provide in summary form the financial information for that immediately preceding sequential quarter that is subject of the discussion or identify the registrant's prior filings on EDGAR that present such information. If there is a change in the form of presentation from period to period that forms the basis of comparison from previous periods provided pursuant to this paragraph, the registrant must discuss the reasons for changing the basis of comparison and provide both comparisons in the first filing in which the change is made.
9250.3 In preparing the interim discussion, the
registrant may presume that the reader has access to the discussion and
analysis required by S-K 303(b) for the preceding fiscal year. The focus
should therefore be on material changes in financial condition and results
of operations. Further discussion of known trends, demands, commitments,
events or uncertainties may be required in interim periods where subsequent
events have occurred or if new information is available that impacts a known
trend, demand, commitment, event or uncertainty.
9250.4 There may also be circumstances where
information was not material in the context of the annual results of
operations but is material in the context of the interim results, and
therefore that information should be discussed (e.g. seasonal aspects of the
business).
9260 Safe Harbor Provisions [Instruction 6 to S-K 303(b)]
Any forward-looking information supplied is expressly covered by the safe harbors
in Rule 175 under the Securities Act and Rule 3b-6 under the Exchange Act
for projections. The safe harbor provisions are intended to protect
forward-looking statements that were made or reaffirmed with a reasonable
basis and in good faith against certain private legal actions alleging
material misstatements or omissions.
9270 SAB Topic 11M (SAB 74)
9270.1 SAB Topic 11M provides disclosure guidance for registrants regarding recently issued accounting standards that have not yet been adopted. The SAB highlights the types of disclosures that should be considered by registrants in MD&A and in the financial statements. It is generally not necessary to provide duplicative disclosure in the MD&A and financial statements, nor is it necessary to provide disclosure for accounting standards that will not apply to a registrant’s financial statements. Registrants should exercise judgment consistent with the SAB in determining the nature, extent, and location of the disclosure.
9270.2 EGCs should also follow Section 10230.3.
9300 [Reserved]
9400 Foreign Private Issuers [Item 5 of Form 20-F]
|
Section
|
Description
|
Last updated
|
|---|---|---|
|
9410
|
Foreign Private Issuers [Item 5 of Form 20-F]
|
8/22/2025
|
9410 Foreign Private Issuers [Item 5 of Form 20-F]
9410.1 The requirements for MD&A are set forth in Item 5 of Form 20-F, under Operating and Financial Review and Prospects (sometimes referred to as the OFR). This Item calls for the same disclosure as S-K 303, so the overall objectives of MD&A are consistent with those set forth above.
9410.2 The requirements of Item 5 of Form 20-F are as follows:
- Operating results — Item 5.A.
- Liquidity and capital resources — Item 5.B.
- Research and development, patents and licenses, etc. — Item 5.C.
- Trend information — Item 5.D.
- Critical Accounting Estimates – Item 5.E.
|
Note: Critical accounting estimate disclosure
is required unless the FPI applies IFRS as issued by
the IASB.
|
9410.3 The discussion must focus on the primary
financial statements in the document. Refer to the reconciliation to U.S.
GAAP and discuss any aspects of the difference between home-country GAAP and
U.S. GAAP (not discussed in the reconciliation) that are necessary for an
understanding of the financial statements as a whole, if applicable.
[Instruction 10 to S-K 303(b); Instruction 2 to Item 5 of Form 20-F]
9410.4 An issuer filing financial statements that
comply with IFRS as issued by the IASB must, in providing information in
response to the paragraphs of Item 5 that refer to pronouncements of the
FASB, provide disclosure that satisfies the objective of the Item 5
disclosure requirements. [Instruction 5 to Item 5 of Form 20-F]
9410.5 Instruction 1 to Item 5 of Form 20-F refers
to the SEC’s interpretive releases No. 33-6835, No. 33-8056, No. 33-8350,
No. 33-9144, and No. 33-10751 for guidance in preparing the discussion and
analysis by management of the company’s financial condition and results of
operations.
9410.6 The requirement under Item 5.C. of Form 20-F
is the only one that does not have a direct correlation to the requirements
in S-K 303. For research and development (R&D), disclosure should be
provided in Form 20-F of the R&D policies over the last three years.
9500 Critical Accounting Estimates [S-K 303(b)(3)]
|
Section
|
Description
|
Last updated
|
|---|---|---|
|
9500
|
Critical Accounting Estimates
|
8/22/2025
|
|
9510
|
Goodwill Impairment
|
8/22/2025
|
|
9520
|
Share-based Compensation in IPOs
|
2/6/2014
|
9500.1 Critical accounting estimates are those estimates made in
accordance with generally accepted accounting principles that involve a
significant level of estimation uncertainty and have had or are reasonably
likely to have a material impact on the financial condition or results of
operations of the registrant.
9500.2 Registrants are required to provide qualitative and quantitative
information necessary to understand the estimation uncertainty and the impact
each critical accounting estimate has had or is reasonably likely to have on
financial condition or results of operations, to the extent the information is
material and reasonably available. This information should include why each
critical accounting estimate is subject to uncertainty and, to the extent the
information is material and reasonably available, how much each estimate and/or
assumption has changed over a relevant period, and the sensitivity of the
reported amount to the methods, assumptions and estimates underlying its
calculation.
9500.3 In analyzing the sensitivity of the reported amounts where the
assumptions are interdependent, a registrant may hold other assumptions constant
in sensitizing a critical assumption and disclose the assumptions in holding
other assumptions constant.
9500.4 This disclosure must supplement, but not duplicate, the description
of accounting policies or other disclosures in the notes to the financial
statements. [Instruction 3 to S-K 303(b)]
9510 Goodwill Impairment
9510.1 Registrants should provide disclosure about
critical accounting estimates pursuant to S-K 303(b)(3). Disclosure is
appropriate when:
-
The nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and
-
The impact of the estimates and assumptions on financial condition or operating performance is material.
9510.2 Estimates related to goodwill impairment testing
are commonly considered critical accounting estimates by registrants. As a
result, the staff has developed the guidance below regarding these
disclosures with the objective of ensuring that investors are provided with
information that allows for an assessment of the probability of a future
material impairment charge. Registrants should consider providing the
disclosures outlined in Section 9510.3 in order to comply with S-K 303(b)(3).
9510.3 Registrants should consider providing the following
disclosures for each reporting unit that is at risk of failing the
quantitative impairment test (defined in ASC 350):
-
The percentage by which fair value exceeded carrying value as of the date of the most recent test;
-
The amount of goodwill allocated to the reporting unit;
-
A description of the methods and key assumptions used, how the key assumptions were determined, and how the key assumptions have changed over a relevant period;
-
A discussion of the degree of uncertainty associated with the key assumptions. The discussion regarding uncertainty should provide specifics to the extent possible (e.g., the valuation model assumes recovery from a business downturn within a defined period of time); and
-
A description of potential events and/or changes in circumstances that could reasonably be expected to negatively affect the key assumptions.
NOTE: A reporting unit may be at risk of failing step one of the impairment test
if it had a fair value that is not substantially in excess of carrying value as of the
date of the last impairment test. Whether or not the fair value was “substantially”
in excess of carrying value is a judgment based on the facts and circumstances
including, but not limited to, the level of uncertainty associated with the methods
and assumptions used for impairment testing. |
9510.4 A registrant need not provide these disclosures if
the registrant asserts and discloses that material goodwill does not exist
at reporting units that are at risk of failing step the quantitative
impairment testone or that no reporting units are at risk. Registrants
should consider disclosing the supporting rationale if material goodwill is
allocated to a reporting unit that is at risk, but disclosure is deemed
unnecessary.
9520 Share-based Compensation in IPOs
9520.1 Estimates used to determine share-based
compensation are often considered critical accounting estimates by companies
going public. In particular, estimating the fair value of the underlying
shares can be highly complex and subjective because the shares are not
publicly traded. The staff will consider if a company performing these
estimates is providing the following critical accounting estimate
disclosures in its IPO prospectus:
- The methods that management used to determine the fair value of the company’s shares and the nature of the material assumptions involved. For example, companies using the income approach should disclose that this method involves estimating future cash flows and discounting those cash flows at an appropriate rate.
- Any specific factors particular to the registrant that make the estimates especially complex and/or subjective.
- The estimates will not be necessary to determine the fair value of new awards once the underlying shares begin trading.
Companies may cross-reference to the extent that this, or other material
information relevant to share-based compensation, is provided elsewhere in
the prospectus.
9520.2
The staff may issue comments asking companies to explain the reasons for
valuations that appear unusual (e.g., unusually steep increases in the fair
value of the underlying shares leading up to the IPO). These comments are
generally intended to elicit analyses that the staff can review to assist it
in confirming the appropriate accounting for the share-based compensation,
and are not necessarily for the purpose of requesting changes to disclosure
in the MD&A or elsewhere in the prospectus.
9520.3 The staff will also consider other MD&A requirements related to share-based compensation, including known trends or uncertainties including, but not limited to, the expected impact on operating results and taxes.
9600 Related Party Transactions
|
Section
|
Description
|
Last updated
|
|---|---|---|
|
9610
|
Related Party Transactions [FR 61]
|
9/30/2008
|
9610 Related Party Transactions [FR 61]
9610.1 In January 2002, a Commission Statement
(Release 33-8056) was issued which addressed several aspects of MD&A,
including disclosures related to the effects of transactions with related
and certain other parties. As discussed in ASC 850-10-50-5, transactions
involving related parties should not be presumed to be carried out on an
arm’s-length basis, as the requisite conditions of a competitive market may
not exist. Accordingly, where material, the disclosure requirements of S-K
404 with respect to certain relationships and transactions with related
parties should be supplemented by additional discussion within MD&A to
the extent necessary for an understanding of the company's current and
prospective financial position and operating results.
9610.2 Disclosure of the following may be necessary, where related party transactions are material:
- The business purpose of the arrangement;
- Identification of the related parties transacting business with the registrant;
- How transaction prices were determined by the parties;
- If disclosures represent that transactions have been evaluated for fairness, a description of how the evaluation was made; and
- Any ongoing contractual or other commitment as a result of the arrangement.
9610.3 Consideration should also be given to whether
disclosure is necessary about parties that fall outside of the definition of
“related parties” set forth in ASC Master Glossary, but with whom the
registrant has a relationship that enables the parties to negotiate terms of
material transactions that may not be available for other, more clearly
independent, parties on an arm’s-length basis. An example of this type of
entity might be a company established and operated by former management of
the registrant.
Disclosure should be provided when an investor might not be able to understand the registrant's reported results of operations without a clear explanation of these arrangements and relationships.
9700 [Reserved]
(Last updated: 8/22/2025)
9800 Other Items
|
Section
|
Description
|
Last updated
|
|---|---|---|
|
9810
|
S-X 3-05 and 3-09
|
9/30/2008
|
|
9820
|
S-X 3-10 and 13-01
|
9/30/2008
|
|
9830
|
Registration and Proxy Statements
|
9/30/2008
|
9810 S-X Acquisition Rules and 3-09
MD&A is not required for financial statements filed to comply with S-X 3-05
and 3-09. However, MD&A of companies being acquired may be required in
registration and proxy statements under the Form requirements (for example,
Items 15-17 of Form S-4 and F-4 and Item 14 of Schedule 14A).
9820 S-X 3-10 and 13-01
9820.1 S-X 3-10 (a)permits the omission of separate
financial statements of subsidiary issuers and guarantors of guaranteed debt
or debt-like securities when certain conditions are met, including that the
parent company provides supplemental financial and non-financial disclosures
about the subsidiary issuers and/or guarantors and the guarantees (see Section 2500). There is no requirement for the
results of operations as presented in these supplemental financial
disclosures to be discussed. However, S-X 13-01 requires certain information
about the issuers, guarantors, and guarantees to be disclosed. If, for
example, there are factors that may affect payments to holders of the
guaranteed security, such as contractual or statutory restrictions on
dividends, or if the information presented in the supplemental financial
disclosures indicates that trends for the issuers and guarantors are
materially different than that of the consolidated entity, this should be
discussed in the liquidity section of MD&A.
9820.2 If separate financial statements of an issuer
or guarantor are filed because it does not qualify for relief under S-X
3-10, then MD&A is required.
9830 Registration and Proxy Statements
9830.1 Registration and proxy statements that
include annual financial statements that have been retroactively revised to
report discontinued operations occurring after the year-end balance sheet
date should include a revised MD&A based on the revised financial
statements. MD&A should describe the events or circumstances that led to
the discontinued operation, the material terms of that termination, and the
impact on the issuer's operating results and business. For example, the
registrant should discuss the results of operations from continuing
operations, and related trends based on the restated financial statements.
In addition, the registrant should discuss any contingent obligations,
financial commitments, or continuing relationship with the discontinued
operation, and any impact on the company's liquidity and capital resources.
Management should also describe the reasonably likely effect the
discontinued operation will have on the registrant's continuing business and
financial health. This discussion may be included in the registration or
proxy statement or in a Form 8-K that includes the restated annual financial
statements incorporated by reference.
9830.2 Similarly, registration and proxy statements
that include annual financial statements that have been retroactively
revised to reflect revised segment reporting, with the revision taking place
after the year-end balance sheet date, should include a revised MD&A
based on the revised segment footnote disclosure. MD&A should address
the change in segment presentation, and explain why the chief operating
decision maker has changed how they make decisions about the allocation of
resources or the assessment of performance. The registrant should discuss
the results of operations on a segmental basis and related trends based on
the revised segmental disclosures included in the restated financial
statements.
9830.3 Registration and proxy statements that
include annual financial statements that have been retroactively revised to
reflect the application of a different accounting principle in accordance
with ASC
250 should also include a revised MD&A if the
changes are material to the previously reported results of operations.
9900 Additional Guidance
|
Section
|
Description
|
Last updated
|
|---|---|---|
|
9910
|
Additional MD&A Guidance
|
8/22/2025
|
9910 Additional MD&A Guidance
9910.1 Additional Guidance Provided in Respect of MD&A Includes:
-
Concept Release on MD&A (No. 33-6711) issued in 1987
-
Management's Discussion and Analysis of Financial Condition and Results of Operations; Certain Investment Company Disclosures (No. 33-6835) issued in 1989, portions of which were codified into FRC 501.
-
Commission Statement about Management’s Discussion and Analysis of Financial Condition and Results of Operations (No. 33-8056) issued in 2002 (FR 61).
-
Commission Guidance Regarding Management's Discussion and Analysis of Financial Condition and Results of Operations (No. 33-8350) issued in 2003 (FR 72).
-
Sample Letter Sent to Public Companies on MD&A Disclosure Regarding the Application of SFAS 157 (Fair Value Measurements) [ASC 820] issued in March 2008.
-
Sample Letter Sent to Public Companies on MD&A Disclosure Regarding the Application of SFAS 157 (Fair Value Measurements) [ASC 820] issued in September 2008.
-
SEC Interpretive Release on Presentation of Liquidity and Capital Resources Disclosures in Management’s Discussion and Analysis (No. 33-9144) issued in September 2010 (FR 83).
-
SEC Interpretive Release on Management’s Discussion and Analysis of Financial Condition and Results of Operations (No. 33-10751) issued in January 2020 (FR 87).
-
SEC Adopting Release on Management’s Discussion and Analysis, Selected Financial Data, and Supplementary Financial Information (No. 33-10890) issued in November 2020.
9910.2 The staff has retained the additional guidance references above
as they generally remain applicable. However, registrants should be aware
that some components of the references above may not be relevant to the
extent they have been subsequently superseded. For example, the guidance for
off-balance sheet arrangements, the table of contractual obligations, and
critical accounting policies has been superseded.
Footnotes
23
Refer to the guidance in Section II.C.3.c. of
SEC Release 33-10890.